U.S. Alcohol Dependence and Abuse Pharmaceuticals Market - Therapeutic Overview and Patient Outlook

리서치사	Frost & Sullivan
발행일	2008년 01월	상품코드	59680
페이지 정보
가격	US $ 6,000 ￦ 7,149,000 Web Access (Regional License) US $ 6,500 ￦ 7,744,700 Hard Copy & Web Access (Regional License)

한글목차
영문목차
관련자료

영문목차

Abstract

This research service covers the U.S. alcohol dependence and abuse pharmaceuticals market from 2003-2013. Included are patient forecasts and a therapeutic overview. The market is segmented by product as follows: Antabuse, Campral, ReVia, and Vivitrol. Major market challenges, drivers, restraints, and strategic recommendations to overcome market challenges are also discussed.

1 EXECUTIVE SUMMARY

Executive Summary
- Introduction

2 TOTAL MARKET

Research Scope and Methodology
- Scope and Segmentation
- Research Methodology
Disease Overview
- Introduction
- Disease Definition
- Signs and Symptoms
- Risk Factors
- Diagnosis
- Treatment
- Health Risks of Excessive Alcohol Consumption
- Disease Statistics
Patient Outlook
- Patient Forecasts
General Market Trends
- Industry Challenges
- Market Drivers
- Market Restraints

3 MARKETED THERAPIES OVERVIEW

Overview
- Antabuse
- Campral
- ReVia
- Vivitrol

4 APPENDIX

Decision Support Databases
- Road Accident Casualties
- Liver Cancer Cases
- Total Consumption of Alcohol
- Per Capita Consumption of Alcohol
- Hypertension Prevalence